Partners

Commercial Partners

CancerGuide is engaged in a development and commercialization collaboration with Laboratory Corporation of America® Holdings (LabCorp®), aimed at bringing personalized care to cancer patients, by providing the medical community with new and more targeted diagnostic laboratory tools.

CancerGuide’s strategic arrangement with LabCorp provides an innovative, development-to-commercial market platform for emerging molecular oncology diagnostic technologies and assays.  Promising clinical products, will gain access to the medical community through LabCorp’s oncology distribution and sales channel, including its subsidiaries, US Labs and DIANON Systems.

LabCorp’s Esoterix global Clinical Trials business unit has exclusive commercial rights to use CancerGuide’s assays in conjunction with pharmaceutical support services.

CancerGuide Seeking In-Licensing Partners

CancerGuide would like to be your high-value oncology diagnostic commercialization partner. If your company or institution is actively licensing novel technology in the oncology field, please register by clicking In-Licensing Registration, with a brief description of your diagnostic technology, platform, intended use, and a listing of peer-reviewed publications.  We look forward to hearing from you.

CancerGuide Seeking Advocacy Partners

CancerGuide is very committed to supporting, educating, and collaborating with cancer advocacy groups. CancerGuide is hopeful that many advocacy groups will understand the tremendous value of the products and services being commercialized, to current and future cancer patients suffering around the world.

As an advocacy organization, there are ways you can assist CancerGuide with our mission:

Establish direct funding support to accelerate the development and commercialization of CancerGuide assays

Establish funding arms for private investors to make donations toward helping patients afford CancerGuide assays

Collaborative communication and awareness initiatives to educate cancer patients, cancer treating physicians, Key opinion leaders, trade organizations, government and private payers, and regulatory authorities.

If interested inexploring an advocacy collaboration, please contact us at advocacy@cancerguidedx.com.